Perception, knowledge, practices and training regarding the risk of exposure to antineoplastic drugs in three French compounding units.

INTRODUCTION Healthcare workers are exposed to hazardous drugs such as antineoplastic drugs, which have potential carcinogenic, mutagenic and teratogenic effects. Protective measures must be taken after appropriate staff training to handle antineoplastic drugs in a safe way. The objective was to assess perception, knowledge, practices and training regarding the risk of exposure of healthcare workers in three French compounding units. METHODS This descriptive study was based on a questionnaire made of 33 questions divided into five sections related to the handling of antineoplastic drugs: perception of the risks, knowledge of the risks, protection practices, specific training and general questions. RESULTS Among the 39 participants, over half considered their overall risk of exposure to antineoplastic drugs not being very low. Inhalation was known to 69.2% of them as possible route of contamination. The breakroom was identified by 28.9% of them as a place of contamination. The procedure in case of accidental exposure to antineoplastic drugs was known by 69.2%, but only half could explain it. Only 38.5% said they changed their gloves every 30 min as recommended. Barely half said that they had been trained specifically for the handling of antineoplastic drugs during an initial training. Over half wished to be informed, trained and aware of the proper handling of antineoplastic drugs. CONCLUSION Although some of these results are encouraging, specifically when compared to the other settings where antineoplastic drugs are handled, there is still room for improvement. Efforts to build an adapted and impactful training program must pursue. CLINICAL TRIAL REGISTRATION Study CONTACT, ref. 19-504.

[1]  N. Simon,et al.  Perception, knowledge, and handling practice regarding the risk of exposure to antineoplastic drugs in oncology day hospitalization units and compounding unit staff. , 2022, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

[2]  Rémy Morello,et al.  Perception, knowledge and protective practices for surgical staff handling antineoplastic drugs during HIPEC and PIPAC , 2022, Pleura and peritoneum.

[3]  R. Delépée,et al.  Impact of low- and high-risk operators handling irinotecan on the blood contamination of health care workers in oncology day care units , 2022, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

[4]  I. Iavicoli,et al.  Exposure to Antineoplastic Drugs in Occupational Settings: A Systematic Review of Biological Monitoring Data , 2022, International journal of environmental research and public health.

[5]  F. Labrèche,et al.  Occupational exposure to antineoplastic drugs: what about hospital sanitation personnel? , 2021, International Archives of Occupational and Environmental Health.

[6]  H. Davies,et al.  Spatial and Temporal Variability in Antineoplastic Drug Surface Contamination in Cancer Care Centers in Alberta and Minnesota. , 2021, Annals of work exposures and health.

[7]  L. Bláha,et al.  The efficiency of antineoplastic drug contamination removal by widely used disinfectants–laboratory and hospital studies , 2021, International Archives of Occupational and Environmental Health.

[8]  Martha Polovich USP General Chapter <800>: Considerations for Oncology Nursing Practice. , 2020, Seminars in oncology nursing.

[9]  R. Delépée,et al.  Does equipment change impact blood contamination with irinotecan and its two major metabolites in a centralized cytotoxic pharmacy unit? , 2020, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

[10]  J. Bussières,et al.  External contamination of commercial containers by antineoplastic agents: a literature review , 2019, European journal of hospital pharmacy : science and practice.

[11]  P. Bonnabry,et al.  Efficiency of degradation or desorption methods in antineoplastic drug decontamination: A critical review , 2019, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

[12]  L. Power,et al.  ASHP Guidelines on Handling Hazardous Drugs , 2018, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[13]  M. Crul,et al.  Carry-over of antineoplastic drug contamination in Dutch hospital pharmacies , 2018, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

[14]  S. Villani,et al.  Monitoring Surface Contamination by Antineoplastic Drugs in Italian Hospitals: Performance-Based Hygienic Guidance Values (HGVs) Project , 2017, Annals of work exposures and health.

[15]  Todd D. Smith,et al.  Effects of organizational safety practices and perceived safety climate on PPE usage, engineering controls, and adverse events involving liquid antineoplastic drugs among nurses , 2017, Journal of occupational and environmental hygiene.

[16]  S. Levorato,et al.  Occupational exposure to cytostatic/antineoplastic drugs and cytogenetic damage measured using the lymphocyte cytokinesis-block micronucleus assay: A systematic review of the literature and meta-analysis. , 2016, Mutation research.

[17]  L. Landeck,et al.  Handling chemotherapy drugs—Do medical gloves really protect? , 2015, International journal of cancer.

[18]  K. Teschke,et al.  Health Care Workers’ Knowledge, Perceptions, and Behaviors Regarding Antineoplastic Drugs: Survey From British Columbia, Canada , 2015, Journal of occupational and environmental hygiene.

[19]  Y. Khader,et al.  Compliance with safe handling guidelines of antineoplastic drugs in Jordanian hospitals , 2015, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

[20]  M. Sweeney,et al.  Adherence to Safe Handling Guidelines by Health Care Workers Who Administer Antineoplastic Drugs , 2014, Journal of occupational and environmental hygiene.

[21]  P. Bonnabry,et al.  Determination of the external contamination and cross-contamination by cytotoxic drugs on the surfaces of vials available on the Swiss market , 2014, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

[22]  K. Teschke,et al.  Antineoplastic Drug Contamination of Surfaces Throughout the Hospital Medication System in Canadian Hospitals , 2013, Journal of occupational and environmental hygiene.

[23]  C. Hon,et al.  Pilot assessment of the antineoplastic drug contamination levels in British Columbian hospitals pre- and post-cleaning , 2012, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

[24]  E. Chatzaki,et al.  Occupational health and safety of personnel handling chemotherapeutic agents in Greek hospitals. , 2011, European journal of cancer care.

[25]  E. Soteriades,et al.  Knowledge, attitudes and beliefs of Cypriot nurses on the handling of antineoplastic agents. , 2010, European journal of oncology nursing : the official journal of European Oncology Nursing Society.

[26]  R. Schierl,et al.  Surface contamination of antineoplastic drug vials: comparison of unprotected and protected vials. , 2010, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[27]  J. Ribak,et al.  The Influence of Nurses' Knowledge, Attitudes, and Health Beliefs on Their Safe Behavior With Cytotoxic Drugs in Israel , 2001, Cancer nursing.